Dr. Duson Stefoski from Rush University in Chicago spoke at Grand Rounds this morning.  Dr. Stefoski is the Director of the Rush Multiple Sclerosis Center and has extensive experience in the diagnosis and management of Progressive Multifocal Leukoencephalopathy (PML). PML is the infection associated with prolonged Tysabri administration, for which there are no approved treatments.  Dr.

By: Dr. James W. Stark

10/9/14 - There has been much discussion in the news regarding some potentially serious viral infections going around close to home as well as around the world, including Enterovirus D68 and Ebola. In addition, we are entering influenza season, which can also be serious in certain patient populations. This is a good time to revisit some basic infection control principles that all of our patients should be doing to protect themselves and their loved ones.

At Grand Rounds this week, Senior Research Scientist,  Dr. Violaine Harris discussed the clinical need for CSF biomarker testing in MS and reviewed current research into the discovery and validation of CSF biomarkers. She highlighted the research from Tisch MS showing that a specific biomarker called Fetuin-A can be an accurate indicator of disease activity and therapeutic response. 

The IMSMP would like to wish all of those observing with their families, a happy Eid Al Adha!

The IMSMP would like to wish our Jewish patients, friends and supporters an easy fast on this Yom Kippur.

9/16/14 - Medscape Medical News recently reviewed the stem cell research presented at the 2014 Joint Americas and European Committees for Treatment and Research in Multiple Sclerosis (ACTRIMS/ECTRIMS).  Read the full article below.


Subscribe to IMSMP Weekly Update